Tevogen Bio announces annual shareholder meeting
TVGN•Annual meeting details
Tevogen Bio Holdings will hold its 2026 annual meeting in a virtual format on Aug. 24, 2026.
Shareholders will vote on electing two Class II directors to three-year terms.
Items include ratifying KPMG as independent auditor for the fiscal year ending Dec. 31, 2026.
Votes are also set on adding 100,000,000 shares to the 2024 Omnibus Incentive Plan share reserve.
A charter amendment to allow shareholder action by written consent is also up for approval.
